Similarly, aspirin and celecoxib reversed cytokine dysregulation in myocardial hypertrophy [56], and celecoxib has shown efficacy in TGF-β-driven disease states [57], likely through NF-κB inhibition [58]. This evidence concerns the gene TGFB1 and cardiac hypertrophy.